Austar Lifesciences (HKSE:06118) COGS-to-Revenue : 0.81 (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Austar Lifesciences COGS-to-Revenue?

Austar Lifesciences's Cost of Goods Sold for the six months ended in Dec. 2024 was HK$687 Mil. Its Revenue for the six months ended in Dec. 2024 was HK$854 Mil.

Austar Lifesciences's COGS to Revenue for the six months ended in Dec. 2024 was 0.81.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Austar Lifesciences's Gross Margin % for the six months ended in Dec. 2024 was 19.49%.

Austar Lifesciences COGS-to-Revenue Historical Data

The historical data trend for Austar Lifesciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Austar Lifesciences COGS-to-Revenue Chart

Austar Lifesciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.75

0.76

0.77

0.81

0.80

Austar Lifesciences Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial															0.76	0.80	0.82	0.79	0.81

Austar Lifesciences COGS-to-Revenue Calculation

Austar Lifesciences's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1280.336	/	1601.937
	=	0.80

Austar Lifesciences's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	687.243	/	853.586
	=	0.81

Austar Lifesciences (HKSE:06118) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Austar Lifesciences's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	687.243 / 853.586
	=	19.49 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Austar Lifesciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Austar Lifesciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Austar Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Austar Lifesciences Ltd (HKSE:06118) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1018 Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN

Website

https://www.austar.com.hk

Austar Lifesciences Ltd is engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipments and consumables in the People's Republic of China. The company's segments include Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC). Geographically, it derives the majority of its revenue from Mainland China.

Executives

True Worth Global Limited	2101 Beneficial owner
Cheung Chau Ping	2202 Interest of your spouse
Ho Kin Hung	2201 Interest of corporation controlled by you

Austar Lifesciences Headlines

No Headlines